Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06278246

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

Sponsor: Centre for Addiction and Mental Health

View on ClinicalTrials.gov

Summary

Within the schizophrenia population, there are individuals that respond to first-line antipsychotic treatments while others do not. The availability of muscarinic M4 subtype receptors (M4R) may play a role as to whether a person with schizophrenia is responsive to first-line antipsychotics or not. The goal of this observational study is to compare the availability of M4R in antipsychotic-free patients with schizophrenia and matched healthy controls. In addition, M4R availability in schizophrenia patients will be examined in relation to response to first line antipsychotics and clinical and cognitive measures. This study may help better understand antipsychotic resistance in schizophrenia and lead to the development of new treatment options, particularly for cognitive deficits and negative symptoms.

Official title: The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

58

Start Date

2024-03-11

Completion Date

2026-03

Last Updated

2025-03-28

Healthy Volunteers

Yes

Interventions

RADIATION

PET Scan

PET scan using the novel \[11C\]MK-6884 tracer to measure M4R during the antipsychotic-free state

Locations (1)

Centre for Addiction and Mental Health

Toronto, Ontario, Canada